# Sinisan ameliorates early-life stress-induced depressive-like behaviors by repairing DRN synaptic damage through CaSR

**Authors:** Qingying Yu, Huan Li, Xulan Cui, Liuchang Zhou, Zedan Xie, Shanshan Wang, Di Deng, Jinlan Zhao, Peng Sun, Yafei Shi, Rong Zhang

PMC · DOI: 10.3389/fphar.2025.1508037 · Frontiers in Pharmacology · 2025-05-21

## TL;DR

Sinisan, a traditional Chinese herbal formula, helps reduce depressive-like behaviors in adolescents caused by early-life stress by repairing brain damage through a receptor called CaSR.

## Contribution

This study reveals that Sinisan rapidly treats stress-induced depression by restoring synaptic damage in the dorsal raphe nucleus via CaSR upregulation.

## Key findings

- Sinisan reversed depressive-like behaviors and synaptic damage in the DRN caused by early-life stress.
- Early-life stress downregulates CaSR in the DRN, and its activation rescues synaptic impairments.
- Pharmacological CaSR activation mimicked the therapeutic effects of Sinisan in stress-induced depression.

## Abstract

Early-life stress (ELS) is a well-established risk factor for adolescent depression, yet the underlying neurobiological mechanisms remain incompletely understood. The dorsal raphe nucleus (DRN), a key serotonergic center, demonstrates stress-induced synaptic impairments that may underlie depressive phenotypes. Sinisan (SNS), a classical Chinese herbal formula, shows clinical efficacy against mood disorders, but its effects on adolescent stress-induced DRN synaptic damage are unknown.

Using a maternal separation plus chronic unpredictable mild stress (MSCUMS) model in adolescent rats, we integrated behavioral tests with various neurobiological analyses. Depressive-like behaviors were evaluated, synaptic ultrastructure in the DRN was examined via electron microscopy, and CaSR expression was measured. The therapeutic effects of SNS and the mechanistic role of CaSR were investigated through pharmacological activation (GdCl3).

MS-CUMS induced: (1) depressive-like behaviors, (2) DRN synaptic ultrastructural damage, and (3) Calcium-sensing receptor (CaSR) downregulation. SNS treatment normalized depression/anxiety behaviors, restored CaSR expression and ameliorated synaptic damage. CaSR activation (GdCl3) reversed these deficits, confirming its mechanistic role.

These results demonstrate that CaSR mediates ELS-induced DRN synaptic impairment, and SNS exerts rapid antidepressant effects via CaSR upregulation.

## Linked entities

- **Proteins:** CASR (calcium sensing receptor)
- **Chemicals:** GdCl3 (PubChem CID 61486)
- **Diseases:** depression (MONDO:0002050)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Casr (calcium-sensing receptor) [NCBI Gene 24247] {aka PCaR1, RaKCaR}
- **Diseases:** anxiety (MESH:D001007), mood disorders (MESH:D019964), Depressive (MESH:D003866), MS (MESH:D009103)
- **Chemicals:** GdCl3 (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12133890/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12133890/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12133890/full.md

---
Source: https://tomesphere.com/paper/PMC12133890